摘要：SummaryTumor heterogeneity and cisplatin resistance are major causes of tumor relapse and poor survival. Here, we show that in lung cancer, interaction between paxillin (PXN) and integrin β4 (ITGB4), components of the focal adhesion (FA) complex, contributes to cisplatin resistance. Knocking down PXN and ITGB4 attenuated cell growth and improved cisplatin sensitivity, both in 2D and 3D cultures. PXN and ITGB4 independently regulated expression of several genes. In addition, they also regulated expression of common genes including USP1 and VDAC1, which are required for maintaining genomic stability and mitochondrial function, respectively. Mathematical modeling suggested that bistability could lead to stochastic phenotypic switching between cisplatin-sensitive and resistant states in these cells. Consistently, purified subpopulations of sensitive and resistant cells re-created the mixed parental population when cultured separately. Altogether, these data point to an unexpected role of the FA complex in cisplatin resistance and highlight a novel non-genetic mechanism.Graphical AbstractDisplay OmittedHighlights•In lung cancer, interaction between PXN and ITGB4 contributes to cisplatin resistance.•Knocking down PXN and ITGB4 attenuated cell growth and improved cisplatin sensitivity.•PXN and ITGB4 regulate expression of USP1 and VDAC1, respectively.•The data underscore a novel non-genetic mechanism for chemoresistance in lung cancer.Cell Biology; Mathematical Biosciences; Cancer
